NCT00354640View on ClinicalTrials.gov

Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

November 30, 2011

Conditions
Breast Cancer
Interventions
DRUG

anastrozole

1 milligram tablet PO QD for 14 days

DRUG

simvastatin

40 milligram tablet PO QD for 14 days

OTHER

pharmacological study

laboratory analysis

PROCEDURE

adjuvant therapy

laboratory analysis

Trial Locations (1)

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00354640 - Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer | Biotech Hunter | Biotech Hunter